B Sonnleitner
Overview
Explore the profile of B Sonnleitner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stark D, Kornmann H, Munch T, Sonnleitner B, Marison I, von Stockar U
Biotechnol Bioeng
. 2003 Jun;
83(4):376-85.
PMID: 12800132
A novel in situ product removal (ISPR) method that uses microcapsules to extract inhibitory products from the reaction suspension is introduced into fermentation technology. More specifically, L-phenylalanine (L-Phe) was transformed...
2.
Stark D, Munch T, Sonnleitner B, Marison I, von Stockar U
Biotechnol Prog
. 2002 Jun;
18(3):514-23.
PMID: 12052068
The bioconversion of L-phenylalanine (L-Phe) to 2-phenylethanol (PEA) by the yeast Saccharomyces cerevisiae is limited by the toxicity of the product. PEA extraction by a separate organic phase in the...
3.
Sonnleitner B
Adv Biochem Eng Biotechnol
. 1999 Dec;
66:1-64.
PMID: 10592525
Modern bioprocesses are monitored by on-line sensing devices mounted either in situ or externally. In addition to sensor probes, more and more analytical subsystems are being exploited to monitor the...
4.
Rothen S, Sauer M, Sonnleitner B, Witholt B
Biotechnol Bioeng
. 1999 Apr;
58(4):356-65.
PMID: 10099269
E. coli HB101[pGEc47], which is able to convert octane to octanoate, but cannot oxidize octanoate further, was grown on defined medium with glucose as carbon source in batch and continuous...
5.
Rothen S, Sauer M, Sonnleitner B, Witholt B
Biotechnol Bioeng
. 1999 Apr;
58(1):92-100.
PMID: 10099265
This paper shows that differences in growth behavior of Escherichia coli strain HB101 and strain HB101[pGEc47] can be related to yeast extract-enriched medium rather than plasmid properties. An optimal medium...
6.
Sonnleitner B
J Biotechnol
. 1998 Nov;
65(1):47-60.
PMID: 9828453
This contribution gives paradigms for static and dynamic effectors of microbial cultures. Macroscopic and physiological steady states are differentiated. The examples comprise: inhibitory and regulatory effects of medium components affecting...
7.
Larsson G, Jorgensen S, Pons M, Sonnleitner B, Tijsterman A
J Biotechnol
. 1998 Mar;
59(1-2):3-9.
PMID: 9487715
No abstract available.
8.
Sonnleitner B, Rothen S, Kuriyama H
Biotechnol Prog
. 1997 Jan;
13(1):8-13.
PMID: 9041706
When a continuously grown yeast culture was allowed to rest at the low dilution rate for an extended time period and was then challenged by increasing the dilution rate, applied...
9.
Rothen S, Saner M, Meenakshisundaram S, Sonnleitner B, Fiechter A
J Biotechnol
. 1996 Sep;
50(1):1-12.
PMID: 8987846
The glucose content of the culture liquid during shift experiments and synchronized cultures of Saccharomyces cerevisiae H1022 (ATCC 32167) was monitored using a greatly improved and highly precise FIA. During...
10.
Ponti C, Sonnleitner B, Fiechter A
J Biotechnol
. 1995 Jan;
38(2):183-92.
PMID: 7765809
The performance of the ATS process depends essentially on the oxygen transfer efficiency. Improvement of the mass transfer capacity of a bioreactor allowed to reduce the incubation time necessary to...